Mostrar el registro sencillo del ítem
Paciente femenino de 70 años de edad con diabetes mellitus tipo 2 e infección por Sars Cov 2.
dc.contributor.advisor | Valle Delgado, Verónica María | |
dc.contributor.author | Figueroa Mariscal, Jailin Adriana | |
dc.date.accessioned | 2021-10-19T20:48:34Z | |
dc.date.available | 2021-10-19T20:48:34Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | http://dspace.utb.edu.ec/handle/49000/10235 | |
dc.description | Diabetes mellitus is a complex and multifactorial chronic disease, characterized by the alteration in the metabolism of glucose, fats and proteins. Often, patients who suffer from it have hyperglycemia and, in addition, coronary artery disease is the leading cause of death. Comorbidities associated with diabetes are: overweight and obesity, systemic arterial hypertension, atherogenic dyslipidemia and, in some patients, peripheral vascular disease, kidney damage, neuropathy and retinopathy. Chronic lack of control of the disease is associated with an increased susceptibility to infections, which generally occur with few symptoms, although hyperglycemia is usually magnificent, which worsens the course of infections. Since December 2019, when the disease caused by one of the coronaviruses (severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2), which has been called coronavirus disease 2019 (COVID-19), was identified, there have been some reports that associate the presence of diabetes with an increased risk of mortality. There have been some proposals for pathophysiological mechanisms to try to explain this special evolution in patients with diabetes. Given the presence of coronavirus disease 2019 in our country and an important group of high-risk patients, a review of the pathophysiology and management considerations of this association is presented. | es_ES |
dc.description | Diabetes mellitus is a complex and multifactorial chronic disease, characterized by the alteration in the metabolism of glucose, fats and proteins. Often, patients who suffer from it have hyperglycemia and, in addition, coronary artery disease is the leading cause of death. Comorbidities associated with diabetes are: overweight and obesity, systemic arterial hypertension, atherogenic dyslipidemia and, in some patients, peripheral vascular disease, kidney damage, neuropathy and retinopathy. Chronic lack of control of the disease is associated with an increased susceptibility to infections, which generally occur with few symptoms, although hyperglycemia is usually magnificent, which worsens the course of infections. Since December 2019, when the disease caused by one of the coronaviruses (severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2), which has been called coronavirus disease 2019 (COVID-19), was identified, there have been some reports that associate the presence of diabetes with an increased risk of mortality. There have been some proposals for pathophysiological mechanisms to try to explain this special evolution in patients with diabetes. Given the presence of coronavirus disease 2019 in our country and an important group of high-risk patients, a review of the pathophysiology and management considerations of this association is presented. | es_ES |
dc.description.abstract | La diabetes mellitus es una enfermedad crónica compleja y multifactorial, caracterizado por la alteración en el metabolismo de glucosa, grasas y proteínas. A menudo, los pacientes que la padecen tienen hiperglucemia y, además, enfermedad de las arterias coronarias es la principal causa de muerte. Comorbilidades que asociados con la diabetes son: sobrepeso y obesidad, hipertensión arterial sistémica, dislipidemia aterogénica y, en algunos pacientes, enfermedad vascular periférica, daño renal, neuropatía y retinopatía. Falta de control crónica de la enfermedad se asocia con una mayor susceptibilidad infecciones, que generalmente ocurren con pocos síntomas, aunque la hiperglucemia suele ser magnifica, que empeora el curso de las infecciones. Desde diciembre de 2019, cuando se identificó la enfermedad causado por uno de los coronavirus (coronavirus 2 del síndrome respiratorio agudo severo o SARS-CoV-2), que ha sido llamado enfermedad por coronavirus 2019 (COVID-19) Ha habido algunos informes que asocian la presencia de diabetes con un mayor riesgo de mortalidad. Se han dado algunos propuestas de mecanismos fisiopatológicos para intentar explicar esta evolución especial en pacientes con diabetes. Dada la presencia de la enfermedad por coronavirus 2019 en nuestro país y un grupo importante de pacientes de alto riesgo, se presenta una revisión de las consideraciones de fisiopatología y manejo de esta asociación. | es_ES |
dc.format.extent | 41 p | es_ES |
dc.language.iso | es | es_ES |
dc.publisher | Babahoyo: UTB-FCS, 2021 | es_ES |
dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Ecuador | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ec/ | * |
dc.subject | Sars Cov2 | es_ES |
dc.subject | Síndrome de Distres Respiratorio Agudo | es_ES |
dc.subject | Diabetes mellitus | es_ES |
dc.subject | Hiperglucemia | es_ES |
dc.subject | Comorbilidades | es_ES |
dc.subject | Síndrome de hiperinflamación sistémica extrapulmonar | es_ES |
dc.title | Paciente femenino de 70 años de edad con diabetes mellitus tipo 2 e infección por Sars Cov 2. | es_ES |
dc.type | bachelorThesis | es_ES |